- Low
- 47,278
- Average
- 47,278
- Median
- 47,278
- High
- 47,278
Glycomimetics Salary
30
73
70
Glycomimetics average salary is $47,278, median salary is $47,278 with a salary range from $47,278 to $47,278.
Glycomimetics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Glycomimetics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Glycomimetics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Glycomimetics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
| Job Title | Salaries | City | Year | More info |
| Accountant | 47,278-47,278 | Sherman Oaks, CA, 91403 | 2017 | Glycomimetics Accountant Salaries (1) Glycomimetics Sherman Oaks, CA Salaries |
Related Glycomimetics Salary
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Glycomimetics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
Guyp Salary Glycomimetics Jobs
| See more Glycomimetics Jobs» | |
| Search All Jobs | |
Patents information
453
All Patents
78
Grant Patents
321
Patents Pending
137
Patents Families
More Recent
-
US11878026B2Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
-
US20240150388A1HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTIN AND GALECTIN-3
-
US20240140976A1PROCESS FOR PREPARING AN E-SELECTIN INHIBITOR INTERMEDIATE
- View More »
Glycomimetics... Information
- GlycoMimetics, Inc
- Industry: BioTech/Drugs
- City: Gaithersburg, MD
- GMI capitalizes on advances in the field of glycobiology by developing small molecule drugs that mimic the action of carbohydrates. GMI acquired the assets of GlycoTech and builds upon a platform technology for designing and screening carbohydrate mimics which was developed over a collaboration between GlycoTech and Ciba-Geigy (later Novartis). GMI is researching the application of novel chemistry technology, which will provide a new approach to rapid synthesis of glycomimetic compounds. GMI will own or have exclusive licenses to 15 issued U.S. patents and 6 additional pending patent applications.
